SG11202005974YA - Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension - Google Patents
Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertensionInfo
- Publication number
- SG11202005974YA SG11202005974YA SG11202005974YA SG11202005974YA SG11202005974YA SG 11202005974Y A SG11202005974Y A SG 11202005974YA SG 11202005974Y A SG11202005974Y A SG 11202005974YA SG 11202005974Y A SG11202005974Y A SG 11202005974YA SG 11202005974Y A SG11202005974Y A SG 11202005974YA
- Authority
- SG
- Singapore
- Prior art keywords
- oxygen
- treatment
- nitric oxide
- pulmonary hypertension
- inhaled nitric
- Prior art date
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title 1
- 229910052760 oxygen Inorganic materials 0.000 title 1
- 239000001301 oxygen Substances 0.000 title 1
- 208000002815 pulmonary hypertension Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1005—Preparation of respiratory gases or vapours with O2 features or with parameter measurement
- A61M16/101—Preparation of respiratory gases or vapours with O2 features or with parameter measurement using an oxygen concentrator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
- A61M16/0666—Nasal cannulas or tubing
- A61M16/0672—Nasal cannula assemblies for oxygen therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/0007—Special media to be introduced, removed or treated introduced into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0208—Oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0266—Nitrogen (N)
- A61M2202/0275—Nitric oxide [NO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Otolaryngology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762611316P | 2017-12-28 | 2017-12-28 | |
| PCT/US2018/067793 WO2019133776A1 (en) | 2017-12-28 | 2018-12-28 | Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202005974YA true SG11202005974YA (en) | 2020-07-29 |
Family
ID=67068194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202005974YA SG11202005974YA (en) | 2017-12-28 | 2018-12-28 | Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20200360425A1 (en) |
| EP (1) | EP3731913A4 (en) |
| JP (1) | JP2021509108A (en) |
| KR (2) | KR20200127157A (en) |
| CN (1) | CN111867664A (en) |
| AU (1) | AU2018394928A1 (en) |
| BR (1) | BR112020012964A2 (en) |
| CA (1) | CA3087195A1 (en) |
| EA (1) | EA202091286A1 (en) |
| IL (1) | IL275678A (en) |
| MX (1) | MX2020006741A (en) |
| PH (1) | PH12020550978A1 (en) |
| SG (1) | SG11202005974YA (en) |
| TW (1) | TW201929841A (en) |
| WO (1) | WO2019133776A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020010523A (en) | 2017-02-27 | 2021-02-09 | Third Pole Inc | Systems and methods for generating nitric oxide. |
| EP4163253A1 (en) | 2017-02-27 | 2023-04-12 | Third Pole, Inc. | Systems and methods for generating nitric oxide |
| EP3585727B1 (en) | 2017-02-27 | 2022-03-16 | Third Pole, Inc. | Systems and methods for ambulatory generation of nitric oxide |
| TW202021637A (en) * | 2018-08-10 | 2020-06-16 | 美商貝勒羅豐治療公司 | Use of inhaled nitric oxide (ino) for the improvement of severe hypoxemia |
| EP3969416A4 (en) | 2019-05-15 | 2023-11-01 | Third Pole, Inc. | Systems and methods for generating nitric oxide |
| CN114269685A (en) | 2019-05-15 | 2022-04-01 | 第三极股份有限公司 | Electrode for nitric oxide generation |
| US11691879B2 (en) | 2020-01-11 | 2023-07-04 | Third Pole, Inc. | Systems and methods for nitric oxide generation with humidity control |
| WO2021243227A1 (en) * | 2020-05-29 | 2021-12-02 | Bellerophon Therapeutics | Method for pulsatile delivery of a gaseous drug |
| WO2021258025A1 (en) | 2020-06-18 | 2021-12-23 | Third Pole, Inc. | Systems and methods for preventing and treating infections with nitric oxide |
| US11975139B2 (en) | 2021-09-23 | 2024-05-07 | Third Pole, Inc. | Systems and methods for delivering nitric oxide |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE025355T2 (en) * | 2006-12-12 | 2016-02-29 | Gilead Sciences Inc | Composition for treating a pulmonary hypertension |
| WO2015148169A1 (en) * | 2014-03-28 | 2015-10-01 | Shape Medical Systems, Inc. | Pattern recognition system for quantifying the likelihood of the contribution of multiple possible forms of chronic disease to patient reported dyspnea |
| AU2016366699A1 (en) * | 2015-12-11 | 2018-06-28 | Vero Biotech LLC | Method and apparatus for administering gases including nitric oxide to address fibrosis |
| WO2017116776A1 (en) * | 2015-12-28 | 2017-07-06 | Geno Llc | Method and apparatus for administering nitric oxide with supplemental drugs |
| EP3413899A4 (en) * | 2016-02-12 | 2019-10-02 | Mallinckrodt Hospital Products IP Limited | Use and monitoring of inhaled nitric oxide with left ventricular assist devices |
-
2018
- 2018-12-28 TW TW107147696A patent/TW201929841A/en unknown
- 2018-12-28 EA EA202091286A patent/EA202091286A1/en unknown
- 2018-12-28 SG SG11202005974YA patent/SG11202005974YA/en unknown
- 2018-12-28 KR KR1020207021817A patent/KR20200127157A/en not_active Application Discontinuation
- 2018-12-28 US US16/961,886 patent/US20200360425A1/en active Pending
- 2018-12-28 WO PCT/US2018/067793 patent/WO2019133776A1/en unknown
- 2018-12-28 JP JP2020535026A patent/JP2021509108A/en active Pending
- 2018-12-28 CA CA3087195A patent/CA3087195A1/en active Pending
- 2018-12-28 MX MX2020006741A patent/MX2020006741A/en unknown
- 2018-12-28 BR BR112020012964-0A patent/BR112020012964A2/en unknown
- 2018-12-28 AU AU2018394928A patent/AU2018394928A1/en active Pending
- 2018-12-28 EP EP18894329.4A patent/EP3731913A4/en active Pending
- 2018-12-28 KR KR1020247026451A patent/KR20240125694A/en active Application Filing
- 2018-12-28 CN CN201880083635.9A patent/CN111867664A/en active Pending
-
2020
- 2020-06-24 PH PH12020550978A patent/PH12020550978A1/en unknown
- 2020-06-25 IL IL275678A patent/IL275678A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240125694A (en) | 2024-08-19 |
| AU2018394928A1 (en) | 2020-07-02 |
| TW201929841A (en) | 2019-08-01 |
| WO2019133776A1 (en) | 2019-07-04 |
| EP3731913A4 (en) | 2021-09-01 |
| EA202091286A1 (en) | 2020-11-05 |
| BR112020012964A2 (en) | 2020-12-01 |
| JP2021509108A (en) | 2021-03-18 |
| EP3731913A1 (en) | 2020-11-04 |
| CA3087195A1 (en) | 2019-07-04 |
| US20200360425A1 (en) | 2020-11-19 |
| CN111867664A (en) | 2020-10-30 |
| KR20200127157A (en) | 2020-11-10 |
| PH12020550978A1 (en) | 2021-04-19 |
| MX2020006741A (en) | 2020-11-24 |
| IL275678A (en) | 2020-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275678A (en) | Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension | |
| IL275683A (en) | Pulsed administration of inhaled nitric oxide for the treatment of pulmonary hypertension | |
| IL272314A (en) | Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease | |
| IL291718A (en) | Oxygen reduction disposable kits, devices and methods of use thereof | |
| GB2599818B (en) | Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract | |
| EP3413899A4 (en) | Use and monitoring of inhaled nitric oxide with left ventricular assist devices | |
| IL281445A (en) | Therapeutic nanoparticles and methods of use thereof | |
| IL261932A (en) | Use of probiotics in the treatment and/or prevention of psoriasis | |
| IL290754A (en) | Use of pridopidine for the treatment of anxiety and depression | |
| HUE056471T2 (en) | Dalargin for use in the treatment of acute respiratory viral infections | |
| IL265881A (en) | Inhaler and methods of use thereof | |
| HUE044731T2 (en) | Formulations for the treatment of disorders of the mouth, throat and respiratory tract | |
| HK1257588A1 (en) | Medicine for preventing and treating lung fibrosis and use of the medicine | |
| EP3541185C0 (en) | Use of 2-hydroxybenzylamine in the treatment and prevention of pulmonary hypertension | |
| EP3703660A4 (en) | Inhalation of nitric oxide | |
| EP3723742C0 (en) | Use of fluoroethylnormemantine for the prevention and treatment of anxiety | |
| IL276792A (en) | Inhaler and methods of use thereof | |
| HK1258614A1 (en) | Nitrous oxide mixtures and methods of use | |
| EP3648789C0 (en) | Mtmr2-s polypeptide for use in the treatment of myopathies | |
| SG11201802955VA (en) | Peptides of use in the preventive and curative treatment of alopecia | |
| EP3703562A4 (en) | Inhalation of nitric oxide | |
| GB201915277D0 (en) | Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract | |
| GB201907971D0 (en) | Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract |